RIGEL PHARMACEUTICALS INC — Director's Dealing 2022

Dec 16, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2022-12-09

Reporting Person: Furey Raymond J. (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$0.8965	2032-12-08	Common Stock (187500)		Direct

Footnotes

F1: One-fourth (1/4th) of the shares subject to this option vest on November 21, 2023, and 1/48th of the shares subject to this option vest in substantially equal monthly installments over the thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.